CA2393614C - Compositions antibacteriennes de clarithromycine et processus de preparation connexe - Google Patents

Compositions antibacteriennes de clarithromycine et processus de preparation connexe Download PDF

Info

Publication number
CA2393614C
CA2393614C CA002393614A CA2393614A CA2393614C CA 2393614 C CA2393614 C CA 2393614C CA 002393614 A CA002393614 A CA 002393614A CA 2393614 A CA2393614 A CA 2393614A CA 2393614 C CA2393614 C CA 2393614C
Authority
CA
Canada
Prior art keywords
weight
composition
clarithromycin
granular
extra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002393614A
Other languages
English (en)
Other versions
CA2393614A1 (fr
Inventor
Azita Saleki-Gerhardt
Rick Rafeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4171189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2393614(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to CA2433962A priority Critical patent/CA2433962C/fr
Priority to CA002393614A priority patent/CA2393614C/fr
Publication of CA2393614A1 publication Critical patent/CA2393614A1/fr
Application granted granted Critical
Publication of CA2393614C publication Critical patent/CA2393614C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Des compositions antibactériennes abrégées de clarithromycine et des méthodes de préparation connexe sont divulguées -15-
CA002393614A 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe Expired - Lifetime CA2393614C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2433962A CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe
CA002393614A CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002393614A CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2433962A Division CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Publications (2)

Publication Number Publication Date
CA2393614A1 CA2393614A1 (fr) 2002-10-28
CA2393614C true CA2393614C (fr) 2003-09-30

Family

ID=4171189

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002393614A Expired - Lifetime CA2393614C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe
CA2433962A Expired - Lifetime CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2433962A Expired - Lifetime CA2433962C (fr) 2002-07-19 2002-07-19 Compositions antibacteriennes de clarithromycine et processus de preparation connexe

Country Status (1)

Country Link
CA (2) CA2393614C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050062514A (ko) * 2002-07-16 2005-06-23 랜박시 래보러터리스 리미티드 경구 투여용 분산성 정제
TR201009167A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefalosporin içeren farmasötik granüller.
TR201010860A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir formulasyonları için üretim yöntemi.

Also Published As

Publication number Publication date
CA2433962A1 (fr) 2002-10-28
CA2393614A1 (fr) 2002-10-28
CA2433962C (fr) 2012-10-30

Similar Documents

Publication Publication Date Title
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
FI79943C (fi) Foerfarande foer framstaellning av en oralt administrerbar farmaceutisk multipelenhetsberedning.
EP2283822A2 (fr) Procédés de séchage par atomisation pour former des dispersions amorphes solides de médicaments et de polymères
PT642785E (pt) Sistemas de hidrogel heterodisperso de libertacao sustida
CN1407894A (zh) 药物组合物
JPH10194969A (ja) 錠剤組成物
JP2003073261A (ja) 難溶性薬物を含む医薬用固形製剤の製造方法
CN100490807C (zh) 一种头孢呋辛酯脂质体、其制备方法及含有它的药物组合物
CZ20011845A3 (cs) Farmaceutické přípravky obsahující cefuroximaxetil
JP2008127349A (ja) 固形組成物
DK2665466T3 (en) Solid molecular dispersion of fesoterodine
CA2634006C (fr) Compositions pharmaceutiques a liberation prolongee comprenant de la liothyronine ou du sel de sodium de liothronine
CA2393614C (fr) Compositions antibacteriennes de clarithromycine et processus de preparation connexe
KR101343283B1 (ko) 수 현탁성을 향상시킨 세립제
TWI286072B (en) Sleeping medicine formed by coating solid
Chowdary et al. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with β-cyclodextrin
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
CN105435239A (zh) 微晶纤维素在美索舒利制剂中的用途、用于美索舒利的辅料、美索舒利制剂及其制备方法
CN111000813B (zh) 孟鲁司特钠咀嚼片及其制备方法
EP0636023B1 (fr) Procede de sechage par pulverisation d'aminoguanidine
JP4384278B2 (ja) イブプロフェン含有粒剤
JPH04327528A (ja) 経口用固形製剤
US4938966A (en) Controlled release flecainide acetate formulation
JPH08208476A (ja) ニフェジピン含有持続性製剤
EP4445899A1 (fr) Formes posologiques à libération prolongée pour composés à faible solubilité et procédés de préparation de ces formes posologiques à libération prolongée

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220719

MKEX Expiry

Effective date: 20220719